GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bionano Genomics Inc (MEX:BNGO) » Definitions » Other Current Liabilities

Bionano Genomics (MEX:BNGO) Other Current Liabilities : MXN49.7 Mil (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Bionano Genomics Other Current Liabilities?

Bionano Genomics's other current liabilities for the quarter that ended in Mar. 2025 was MXN49.7 Mil.

Bionano Genomics's quarterly other current liabilities increased from Sep. 2024 (MXN83.9 Mil) to Dec. 2024 (MXN471.8 Mil) but then declined from Dec. 2024 (MXN471.8 Mil) to Mar. 2025 (MXN49.7 Mil).

Bionano Genomics's annual other current liabilities increased from Dec. 2022 (MXN319.4 Mil) to Dec. 2023 (MXN1,421.7 Mil) but then declined from Dec. 2023 (MXN1,421.7 Mil) to Dec. 2024 (MXN471.8 Mil).

Bionano Genomics Other Current Liabilities Historical Data

The historical data trend for Bionano Genomics's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bionano Genomics Other Current Liabilities Chart

Bionano Genomics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only 66.92 92.91 319.42 1,421.73 471.78

Bionano Genomics Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 229.38 70.51 83.90 471.78 49.65

Bionano Genomics Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Bionano Genomics Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Bionano Genomics's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Bionano Genomics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bionano Genomics Inc (MEX:BNGO) » Definitions » Other Current Liabilities
Comparable Companies
YBGJ EKSO MHUA POAI CBSC LUCY STSS RSCF ECIA GCTK ISRG XPAR:EL BDX XSWX:ALC TSE:7741 RMD TSE:4543 XPAR:DIM OCSE:COLO B XSWX:STMN
Traded in Other Exchanges
BNGO:USA
Address
9540 Towne Centre Drive, Suite 100, San Diego, CA, USA, 92121
Website
https://www.bionano.com
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.